Braidwell »

Guardant Health shares owned by Braidwell

Quarter-by-quarter ownership of Guardant Health (GH) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Guardant Health

Tip: Access up to 7 years of quarterly data

All positions including Guardant Health held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Guardant Health by Braidwell

Quarter filed Position value Share count Share price at filing
2023-12-31 $21M 759k 27.05
2023-09-30 $20M 689k 29.64
2023-06-30 $9.7M 270k 35.80

More positions owned by Braidwell

Guardant Health Note 11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Exact Sciences Corp Note 0.375% 3/0 (Principal)
Novocure Note 11/0 (Principal)
Neurocrine Biosciences (NBIX)
Vaxcyte (PCVX)
Xenon Pharmaceuticals (XENE)
Nuvasive Note 0.375% 3/1 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Tandem Diabetes Care Note 1.500% 5/0 (Principal)
Day One Biopharmaceuticals I (DAWN)
Irhythm Technologies (IRTC)
Argenx Se Sponsored Adr (ARGX)
Bridgebio Pharma Note 2.250% 2/0 (Principal)

View all positions for Braidwell

Top funds holding Guardant Health

Vanguard Group
Baillie Gifford & Co
Eventide Asset Management
Alliancebernstein
Parkwood
T. Rowe Price Associates
Credit Suisse
ClearBridge Advisors
Franklin Resources
Charles Schwab Investment Management
Deutsche Bank Aktiengesellschaft
Man Group
Bank of New York Mellon
Norges Bank Investment Management
Goldman Sachs Group

View all funds holding Guardant Health